NCT00004547 · OUTCOME

Signal Transduction Pathways in Tumor Tissue Versus Normal Tissue

Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy · Source last updated 2015-11-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: once during surgery

What was measured

Signal transduction pathways were measured using reverse phase protein lysate microarray to determine if the pathways are distinct in tumor versus normal tissue.

Analysis population: This outcome measure was not analyzed because it was not feasible.

Groups in this outcome

Normal Tissue

Non-diseased tissue

Tumor Tissue

Diseased tissue

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Normal Tissue	0
Tumor Tissue	0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

denoms

counts
group Id
OG000
value
0
group Id
OG001
value
0
units
Participants

description

Signal transduction pathways were measured using reverse phase protein lysate microarray to determine if the pathways are distinct in tumor versus normal tissue.

groups

description
Non-diseased tissue
id
OG000
title
Normal Tissue
description
Diseased tissue
id
OG001
title
Tumor Tissue

population Description

This outcome measure was not analyzed because it was not feasible.

reporting Status

POSTED

time Frame

once during surgery

title

Signal Transduction Pathways in Tumor Tissue Versus Normal Tissue

type

SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice